ALLO - Allogene Therapeutics' (ALLO) CEO David Chang on Q3 2020 Results - Earnings Call Transcript

Allogene Therapeutics, Inc. (ALLO) Q3 2020 Earnings Conference Call November 4, 2020 8:30 AM ET Company Participants Christine Cassiano – Chief Communications Officer David Chang – President and Chief Executive Officer Rafael Amado – Executive Vice President-Research and Development and Chief Medical Officer Eric Schmidt – Chief Financial Officer Conference Call Participants Marc Frahm – Cowen Salveen Richter – Goldman Sachs Brian Ayman – Jefferies Tyler Van Buren – Piper Sandler John Newman – Canaccord Cory Kasimov – JPMorgan Michael Schmidt – Guggenheim Mark Breidenbach – Oppenheimer Dane Leone – Raymond James Reni Benjamin – JMP Securities Raju Prasad – William Blair Asthika Goonewardene – Truist Securities Luca Issi – RBC Capital Ben Burnett – Stifel Presentation Operator Good morning, ladies and gentlemen. Thank you for standing by, and welcome to Allogene Therapeutics Third Quarter 2020 Conference Call. At this time, all participants are in a listen-only mode. After the

For further details see:

Allogene Therapeutics' (ALLO) CEO David Chang on Q3 2020 Results - Earnings Call Transcript